We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-4.53%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$7.65B
AUM Growth
-$2.07B
Cap. Flow
-$890M
Cap. Flow %
-11.64%
Top 10 Hldgs %
69.25%
Holding
109
New
20
Increased
5
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ONON icon
On Holding
ONON
+$561M
2
LEGN icon
Legend Biotech
LEGN
+$433M
3
CTKB icon
Cytek Biosciences
CTKB
+$206M
4
SE icon
Sea Limited
SE
+$101M
5
ERAS icon
Erasca
ERAS
+$97.4M

Top Sells

Rank Stock Value
1
ESGR
Enstar Group
ESGR
+$418M
2
PDD icon
Pinduoduo
PDD
+$398M
3
ZM icon
Zoom
ZM
+$398M
4
ABNB icon
Airbnb
ABNB
+$300M
5
UBER icon
Uber
UBER
+$188M

Sector Composition

Rank Sector Weight
1 Healthcare 57.57%
2 Consumer Discretionary 24.98%
3 Technology 6.63%
4 Communication Services 6.51%
5 Consumer Staples 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLYB icon
51
Rallybio
RLYB
$90M
$15.9M 0.21%
+112,959
New +$13.2M
IPSC icon
52
Century Therapeutics
IPSC
$353M
$15.5M 0.2%
614,095
– –
TUYA
53
Tuya Inc
TUYA
$1.09B
$15.3M 0.2%
1,689,359
-685,641
-29% -$10.6M
ROOT icon
54
Root
ROOT
$845M
$13.7M 0.18%
144,444
– –
EM
55
DELISTED
Smart Share Global Ltd
EM
$13.6M 0.18%
4,080,000
– –
ADCT icon
56
ADC Therapeutics
ADCT
$134M
$13.6M 0.18%
500,000
– –
HIPO icon
57
Hippo Holdings
HIPO
$852M
$13M 0.17%
+110,868
New +$19.4M
BEDU
58
DELISTED
Bright Scholar Education Holdings
BEDU
$11.4M 0.15%
996,449
– –
TCRX icon
59
TScan Therapeutics
TCRX
$21M
$10.7M 0.14%
+1,282,976
New +$11.9M
TRML
60
DELISTED
Tourmaline Bio
TRML
$10.3M 0.14%
76,189
-9,145
-11% -$1.25M
IMCR icon
61
Immunocore
IMCR
$1.63B
$10.3M 0.13%
277,754
– –
MOGU
62
MOGU Inc
MOGU
$15.4M
$10.1M 0.13%
870,581
– –
KDP icon
63
Keurig Dr Pepper
KDP
$42.9B
$9.73M 0.13%
284,792
-284,792
-50% -$9.96M
SRZN icon
64
Surrozen
SRZN
$208M
$8.5M 0.11%
+80,000
New +$11.3M
PATH icon
65
UiPath
PATH
$7.58B
$7.89M 0.1%
150,000
– –
ZTO icon
66
ZTO Express
ZTO
$15.5B
$7.86M 0.1%
256,453
-2,344,324
-90% -$67.3M
AMD icon
67
Advanced Micro Devices
AMD
$825B
$7.2M 0.09%
+70,000
New +$7.16M
MREO
68
Mereo BioPharma
MREO
$44.7M
$7.2M 0.09%
2,976,121
– –
UXIN
69
Uxin Ltd
UXIN
$244M
$6.34M 0.08%
22,973
– –
RXDX
70
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$4.74M 0.06%
200,000
– –
XPEV icon
71
XPeng
XPEV
$9.83B
$4.26M 0.06%
120,000
-776,500
-87% -$30.8M
DSGN icon
72
Design Therapeutics
DSGN
$774M
$4.13M 0.05%
280,991
– –
MNSO icon
73
MINISO
MNSO
$2.63B
$3.85M 0.05%
252,322
-5,401,154
-96% -$82.4M
KRON
74
DELISTED
Kronos Bio
KRON
$3.22M 0.04%
153,698
-279,738
-65% -$6.01M
RDGT
75
Ridgetech Inc
RDGT
$2.96M
$3.08M 0.04%
134
– –
1 2
3
4 5

Similar funds

ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $832M AUM 5.47% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
AFA
AA Financial Advisors Columbus, Ohio $832M AUM 20.55% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $833M AUM 25.55% 1-Year Est. Return
AFA
American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $835M AUM 73.7% 1-Year Est. Return

HHLR Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, HHLR Advisors held 109 positions worth $7.65B, down 21% from $9.71B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HHLR Advisors withdrew a net $890M in Q3 2021, closing 24 positions and reducing 15 holdings. Its most notable exit was Enstar Group, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in On Holding worth $481M.

  • HHLR Advisors's largest Q3 2021 buy was On Holding: 15,973,750 shares worth $481M.
  • HHLR Advisors added most to Legend Biotech in Q3 2021, an estimated $433M increase.
  • HHLR Advisors's biggest Q3 2021 reduction was Pinduoduo, cutting an estimated $398M.
  • HHLR Advisors fully exited Enstar Group in Q3 2021, selling an estimated $418M.
  • HHLR Advisors's ten largest holdings make up 69% of its $7.65B portfolio in Q3 2021.
  • HHLR Advisors opened 20 new positions and closed 24 in Q3 2021.
  • HHLR Advisors's portfolio value fell 21% quarter-over-quarter to $7.65B.

Based on HHLR Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.